# Precision Radiotherapy Using MR-linac for Pancreatic Neuroendocrine Tumours in MEN1 Patients

> **NCT05037461** · NA · RECRUITING · sponsor: **J.M. de Laat** · enrollment: 20 (estimated)

## Conditions studied

- Neuroendocrine Tumor of Pancreas
- Multiple Endocrine Neoplasia Type 1

## Interventions

- **RADIATION:** High-dose-high precision MR-guided radiotherapy

## Key facts

- **NCT ID:** NCT05037461
- **Lead sponsor:** J.M. de Laat
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-05-01
- **Primary completion:** 2025-12-01
- **Final completion:** 2026-12-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2024-12-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05037461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05037461, "Precision Radiotherapy Using MR-linac for Pancreatic Neuroendocrine Tumours in MEN1 Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05037461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*